Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001178913-23-002598
Filing Date
2023-07-28
Accepted
2023-07-28 16:05:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 PRER14A zk2330042.htm PRER14A 730119
2 image0.jpg GRAPHIC 2436
3 image00001.jpg GRAPHIC 2114
  Complete submission text file 0001178913-23-002598.txt   737656
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-38556 | Film No.: 231123033
SIC: 2836 Biological Products, (No Diagnostic Substances)